SHA:688621 Revenue

In the year 2025, Beijing Sun-Novo Pharmaceutical Research had annual revenue of 1.22B CNY with 12.92% growth. Beijing Sun-Novo Pharmaceutical Research had revenue of 362.05M in the quarter ending December 31, 2025, with 123.77% growth.

Revenue

1.22B

Revenue Growth

+12.92%

P/S Ratio

5.75

Revenue / Employee

782.66K

Employees

1,359

Market Cap

7.00B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.22B	139.34M	12.92%
Dec 31, 2024	1.08B	146.35M	15.70%
Dec 31, 2023	932.12M	255.51M	37.76%
Dec 31, 2022	676.61M	182.96M	37.06%
Dec 31, 2021	493.65M	146.29M	42.12%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shanghai Kaibao Pharmaceutical CO.,Ltd	1.17B
Guizhou Bailing Group Pharmaceutical	3.15B
Tibet Duo Rui Pharmaceutical	177.11M
Heilongjiang ZBD Pharmaceutical	1.59B
ChengDa Pharmaceuticals	374.46M
Jiangsu Lianhuan Pharmaceutical	2.60B
Jiuzhitang	1.94B
Beijing SL Pharmaceutical	578.61M

Revenue Rankings